Ricerca avanzata

Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 Settembre;51(3) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 Settembre;51(3):260-71

FASCICOLI E ARTICOLI   I PIÙ LETTI   eTOC

ULTIMO FASCICOLOTHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare

A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413

Periodicità: Trimestrale

ISSN 1824-4785

Online ISSN 1827-1936

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 Settembre;51(3):260-71

ADVANCES IN PET - PART I 

 REVIEWS

PET in genitourinary tract cancers

Fanti S. 1, Nanni C. 1, Ambrosini V. 1, Gross M. D. 2, Rubello D. 3, Farsad M. 1

1 Unit of Nuclear Medicine S.Orsola-Malpighi Polyclinic, Bologna, Italy
2 Nuclear Medicine Service, Veterans Affairs Hospital Ann Arbor, MI, USA
3 Unit of Nuclear Medicine S. Maria della Misericordia Rovigo Hospital, Rovigo, Italy

Genitourinary (GU) tract cancers comprise a variety of tumors, which includes some of the most common malignancies in men and women. As a result of the importance of GU neoplasms and the success of positron emission tomography (PET) in imaging and staging cancer, PET with fluorodeoxyglucose (FDG) has been used to depict and stage ovarian, cervical and testicular cancers. The early success of FDG PET in imaging GU tumors is tempered by the fact that some neoplasms of GU origin do not accumulate sufficient FDG for successful imaging. As a result, alternative agents, such as [11C]choline and [11C]acetate, have been used to image prostate cancer and may have utility in bladder cancer, while other PET agents are currently under active evaluation for this and other GU neoplasms. In this paper, we review the current literature and our experience in role of PET in imaging cancers of the GU tract.

lingua: Inglese


FULL TEXT  ESTRATTI

inizio pagina